Feprosidnine
Feprosidnine is a stimulant drug that was developed in the Soviet Union in the 1970s. It is chemically related to the drug prosidnine and has been used for its nootropic and psychostimulant effects.
Chemical Structure and Properties[edit]
Feprosidnine is a derivative of prosidnine, with the chemical structure of 2-(2-furyl)-2-phenyl-2-(1-pyrrolidinyl)ethanol. It is a member of the pyrrolidine class of compounds, which are known for their stimulating effects on the central nervous system.
Pharmacology[edit]
Feprosidnine acts primarily as a dopamine reuptake inhibitor, which increases the levels of dopamine in the brain. This action is similar to that of other stimulant drugs such as methylphenidate and amphetamine. The increased dopamine levels are associated with enhanced cognitive function, improved memory, and increased alertness.
Medical Uses[edit]
Feprosidnine has been used in the treatment of various conditions, including attention deficit hyperactivity disorder (ADHD), narcolepsy, and certain types of depression. Its nootropic effects have also made it a subject of interest for enhancing cognitive performance in healthy individuals.
Side Effects[edit]
Common side effects of feprosidnine include insomnia, anxiety, headache, and nausea. In some cases, it may also cause tachycardia and hypertension. Long-term use can lead to tolerance, dependence, and addiction.
Legal Status[edit]
The legal status of feprosidnine varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and addiction. In others, it may be available by prescription for specific medical conditions.
Research[edit]
Research on feprosidnine has primarily focused on its potential as a cognitive enhancer and its effects on the central nervous system. Studies have shown that it can improve learning and memory in animal models, but more research is needed to fully understand its effects in humans.
See Also[edit]
References[edit]
External Links[edit]
-
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian